Figure 1.

Study population flow chart. The patients with MI and diabetes who underwent PCI were enrolled. We excluded the patients occurred in-hospital switching between antiplatelet agents, those inappropriately used prasugrel, or those had missing data about antiplatelet agents or clinical outcomes. Total 3985 patients were enrolled. Among them, 2985 patients included clopidogrel group and 1000 patients included the prasugrel/ticagrelor group. MI = myocardial infarction, PCI = percutaneous coronary intervention.